RACHEL FRANCIS: Open Payments
NPI 1699045526 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 39 payments from 14 companies in 2025. Trend: 2023 $846 · 2024 $939 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $372 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| Tandem Diabetes Care, Inc. | 4 | $61 |
| GENZYME CORPORATION | 1 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Sequel Med Tech, LLC | 1 | $34 |
| Dexcom, Inc. | 2 | $28 |
| Amgen Inc. | 2 | $27 |
| Abbott Laboratories | 1 | $25 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
Products named: Wegovy, Ozempic, FARXIGA, Rybelsus, t:slim X2 Insulin Pump with Control-IQ, DUPIXENT, JARDIANCE, TWIIST.
Industry payments across FL — which companies pay providers there.
